Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ORGO
FechaHoraFuenteTítuloSímboloCompañía
06/06/202415:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202415:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202415:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
02/05/202406:00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
16/04/202406:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
03/04/202406:30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202415:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202415:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202416:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
12/02/202406:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
08/02/202415:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
02/02/202408:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ORGOOrganogenesis Holdings Inc
09/01/202415:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
09/11/202315:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
05/10/202306:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
28/09/202308:15GlobeNewswire Inc.Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGSNASDAQ:ORGOOrganogenesis Holdings Inc
06/09/202315:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202315:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
10/07/202306:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202315:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202315:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202315:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
01/05/202315:13Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ORGOOrganogenesis Holdings Inc
01/05/202315:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ORGOOrganogenesis Holdings Inc
27/04/202306:30GlobeNewswire Inc.Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of DirectorsNASDAQ:ORGOOrganogenesis Holdings Inc
14/04/202317:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORGOOrganogenesis Holdings Inc
10/04/202306:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
06/04/202308:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORGOOrganogenesis Holdings Inc
27/03/202307:00GlobeNewswire Inc.Organogenesis Applauds Findings from the Office of Inspector GeneralNASDAQ:ORGOOrganogenesis Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ORGO